The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Particle design using supercritical fluids: Literature and patent survey
Jung, J., & Perrut, M. (2001) · The Journal of Supercritical Fluids · doi:10.1016/s0896-8446(01)00064-x · Cited by 1,141
Protein drug stability: a formulation challenge
Frokjaer, S., & Otzen, D. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1695 · Cited by 1,096
Instability, stabilization, and formulation of liquid protein pharmaceuticals
Wang, W. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00152-0 · Cited by 1,064
Protein aggregation and its inhibition in biopharmaceutics
Wang, W. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.014 · Cited by 983
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
Caliceti, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00108-x · Cited by 947
Globular proteins at solid/liquid interfaces
Haynes, C. A., & Norde, W. (1994) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/0927-7765(94)80066-9 · Cited by 852
Biodegradable microspheres for protein delivery
Sinha, V. R., & Trehan, A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00194-9 · Cited by 814
Lipid vesicles and other colloids as drug carriers on the skin
Cevc, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.028 · Cited by 700
Immobilised enzymes: science or art?
Cao, L. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.02.014 · Cited by 634
Physicochemical Principles of Pharmacy
Florence, A. T., & Attwood, D. (1981) · doi:10.1007/978-1-349-19480-3 · Cited by 587
Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
UGWOKE, M., AGU, R., VERBEKE, N., & KINGET, R. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.009 · Cited by 543
Immobilization of lipases by selective adsorption on hydrophobic supports
Fernandez-Lafuente, R., Armisén, P., Sabuquillo, P., Fernández-Lorente, G., & M. Guisán, J. (1998) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(98)00042-5 · Cited by 501
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012029517394 · Cited by 499
Müller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., Mühlen, A. Z., Meyhers, H., de Freitas, C. F., & Rühl, D. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 455
Biodegradable Polymers for Protein and Peptide Drug Delivery
Gombotz, W. R., & Pettit, D. K. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00034a002 · Cited by 448
The vagina as a route for systemic drug delivery
Hussain, A., & Ahsan, F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.034 · Cited by 435
In situ forming parenteral drug delivery systems: an overview
Packhaeuser, C. B., Schnieders, J., Oster, C. G., & Kissel, T. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.003 · Cited by 413
The lung as a route for systemic delivery of therapeutic proteins and peptides
Uchenna Agu, R., Ikechukwu Ugwoke, M., Armand, M., Kinget, R., & Verbeke, N. (2001) · Respiratory Research · doi:10.1186/rr58 · Cited by 411
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 380
Cosmetic applications for solid lipid nanoparticles (SLN)
Wissing, S. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00684-1 · Cited by 364
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Pandey, R., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.11.003 · Cited by 318
Immunity in response to particulate antigen-delivery systems
STORNI, T., KUNDIG, T., SENTI, G., & JOHANSEN, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.008 · Cited by 317
Fundarò, A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P., & Gasco, M. R. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0695 · Cited by 317
Formulation aspects of biodegradable polymeric microspheres for antigen delivery
TAMBER, H., JOHANSEN, P., MERKLE, H., & GANDER, B. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.002 · Cited by 316
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Self-citationStructure, Stability, and Activity of Adsorbed Enzymes
Zoungrana, T., Findenegg, G. H., & Norde, W. (1997) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1997.4895 · Cited by 290
Drug Delivery: Engineering Principles for Drug Therapy
Saltzman, W. M. (2001) · Cited by 287
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
ALPAR, H., SOMAVARAPU, S., ATUAH, K., & BRAMWELL, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.004 · Cited by 287
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin
Zhang, N., Ping, Q., Huang, G., Xu, W., Cheng, Y., & Han, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.026 · Cited by 286
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
Garcı́a-Fuentes, M., Torres, D., & Alonso, M. J. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(02)00053-x · Cited by 273
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Pandey, R., Sharma, S., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.08.009 · Cited by 271
Nanoparticle uptake by the oral route: Fulfilling its potential?
Florence, A. T. (2005) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2005.05.019 · Cited by 248
Langer, R. (2003) · Scientific American · doi:10.1038/scientificamerican0403-50 · Cited by 229
Drug delivery in biotechnology: present and future
Orive, G., Hernández, R. M., Gascón, A. R., Domı́nguez-Gil, A., & Pedraz, J. L. (2003) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2003.10.007 · Cited by 223
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
Göppert, T. M., & Müller, R. H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.025 · Cited by 221
Sjöström, B., & Bergenståhl, B. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90303-j · Cited by 215
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000054933 · Cited by 213
Self-citationSLN and NLC for topical delivery of ketoconazole
Souto, E. B., & Müller, R. H. (2005) · Journal of Microencapsulation · doi:10.1080/02652040500162436 · Cited by 208
Self-citationZara, G. P., Cavalli, R., Bargoni, A., Fundarò, A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Drug Targeting · doi:10.1080/10611860290031868 · Cited by 207
Shifting paradigms: biopharmaceuticals versus low molecular weight drugs
Crommelin, D. J. A., Storm, G., Verrijk, R., de Leede, L., Jiskoot, W., & Hennink, W. E. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00376-4 · Cited by 197
Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
Almeida, A. J., Runge, S., & Müller, R. H. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)04885-0 · Cited by 193
Self-citationNew generation of mucosal adjuvants for the induction of protective immunity
Yuki, Y., & Kiyono, H. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.398 · Cited by 191
Lipid microparticles as a parenteral controlled release device for peptides
Reithmeier, H., Herrmann, J., & Göpferich, A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00354-6 · Cited by 173
MYLES, M., NEUMANN, D., & HILL, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.08.006 · Cited by 171
Garcia-Fuentes, M., Prego, C., Torres, D., & Alonso, M. J. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.02.008 · Cited by 171
Incorporation of cyclosporin A in solid lipid nanoparticles (SLN)
Ugazio, E., Cavalli, R., & Gasco, M. R. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00268-5 · Cited by 168
Preparation and characterization of solid lipid nanoparticles containing peptide
Hu, F. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.016 · Cited by 168
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin
GARCIAFUENTES, M., TORRES, D., & ALONSO, M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.030 · Cited by 161
Smart, J. D. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.3.507 · Cited by 161
Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN)
Göppert, T. M., & MULLER, R. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.02.006 · Cited by 145
Drug Delivery and Targeting : For Pharmacists and Pharmaceutical Scientists
Hillery, A. M., Lloyd, A. W., & Swarbrick, J. (2001) · Cited by 144
Strategies to improve oral drug bioavailability
Gómez-Orellana, I. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.3.419 · Cited by 144
Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats
Bosquillon, C., Préat, V., & Vanbever, R. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.027 · Cited by 140
Formulation and Delivery of Proteins and Peptides
Cleland, J. L., & Langer, R. (1994) · ACS symposium series · doi:10.1021/bk-1994-0567 · Cited by 134
Development and characterization of lipid microparticles as a drug carrier for somatostatin
Reithmeier, H., Herrmann, J., & Göpferich, A. M. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00620-2 · Cited by 132
Delivery systems for penetration enhancement of peptide and protein drugs: design considerations.
Kompella, U. B., & Lee, V. H. L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00137-x · Cited by 131
Emerging strategies for the transdermal delivery of peptide and protein drugs
Schuetz, Y. B., Naik, A., Guy, R. H., & Kalia, Y. N. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.3.533 · Cited by 127
Norde, W., & Zoungrana, T. (1998) · Biotechnology and Applied Biochemistry · doi:10.1111/j.1470-8744.1998.tb00523.x · Cited by 126
Thymopentin in solid lipid nanoparticles
Morel, S., Ugazio, E., Cavalli, R., & Gasco, M. R. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04388-8 · Cited by 123
Fernandes, A. I., & Gregoriadis, G. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00603-2 · Cited by 119
Almeida, A. J., & Alpar, H. O. (1996) · Journal of drug targeting · doi:10.3109/10611869609015965 · Cited by 117
Self-citationSellers, S. P., Clark, G. S., Sievers, R. E., & Carpenter, J. F. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1032 · Cited by 116
Almeida, A. J., Alpar, H. O., & Brown, M. R. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb05532.x · Cited by 116
Self-citationStudies on the cyclosporin A loaded stearic acid nanoparticles
Zhang, Q., Yie, G., Li, Y., Yang, Q., & NAGAI, T. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00361-6 · Cited by 114
Sznitowska, M., Gajewska, M., Janicki, S., Radwanska, A., & Lukowski, G. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00157-6 · Cited by 113
Stabilization of proteins in dry powder formulations using supercritical fluid technology
Jovanović, N., Bouchard, A., Hofland, G. W., Witkamp, G.-J., Crommelin, D. J. A., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000048185.09483.e7 · Cited by 111
The potential of chitosan for the oral administration of peptides
Prego, C., Torres, D., & Alonso, M. J. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.5.843 · Cited by 102
Bargoni, A., Cavalli, R., Zara, G. P., Fundaro', A., Caputo, O., & Gasco, M. R. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0813 · Cited by 101
Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion–diffusion technique
Trotta, M., Cavalli, R., Carlotti, M. E., Battaglia, L., & Debernardi, F. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.10.014 · Cited by 99
Microencapsulation of protein particles within lipids using a novel supercritical fluid process
Santos, I. R. D., Richard, J., Pech, B., Thies, C., & Benoît, J. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00149-7 · Cited by 96
Interactions of amphiphilic calix[4]arene-based Solid Lipid Nanoparticles with bovine serum albumin
Gualbert, J., Shahgaldian, P., & Coleman, A. W. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00138-8 · Cited by 84
The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals
Pettit, D. K., & Gombotz, W. R. (1998) · Trends in biotechnology · doi:10.1016/s0167-7799(98)01186-x · Cited by 84
Design and characterization of a new drug nanocarrier made from solid–liquid lipid mixtures
García-Fuentes, M., Alonso, M. J., & Torres, D. (2005) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.10.012 · Cited by 79
Lipid microparticles for mucosal immunization against hepatitis B
Saraf, S., Mishra, D. K., Asthana, A., Jain, R., Singh, S., & Jain, N. K. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.053 · Cited by 69
Interferon-γ therapy: Evaluation of routes of administration and delivery systems
Younes, H. M., & Amsden, B. G. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10007 · Cited by 63
Cavalli, R., Zara, G. P., Caputo, O., et al. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0737 · Cited by 57
Jung, T., Kamm, W., Breitenbach, A., Klebe, G., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019833822997 · Cited by 53
Erni, C., Suard, C., Freitas, S., Dreher, D., Merkle, H. P., & Walter, E. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00216-8 · Cited by 53
Peptide drug delivery: Colonic and rectal absorption
Mackay, M. W., Phillips, J. A., & Hastewell, J. G. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00076-8 · Cited by 53
Lymphatic uptake of lipid nanoparticles following endotracheal administration
Videira, M., Gano, L., dos Santos, C. P., Neves, M., & Almeida, A. J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600788221 · Cited by 49
Self-citationFormulation and delivery of proteins and peptides: design and development strategies.
Jl, C., & Langer, R. (1994) · ACS Symposium series. American Chemical Society · Cited by 47
Lipid microparticles as sustained release system for a GnRH antagonist (Antide)
Curto, M. D. D., Chicco, D., D’Antonio, M., Ciolli, V., Dannan, H., Durso, S., Neuteboom, B., Pompili, S., Schiesaro, S., & Esposito, P. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00120-2 · Cited by 46
Balmelli, C., Demotz, S., Acha‐Orbea, H., Grandi, P. D., & Nardelli‐Haefliger, D. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12596-12602.2002 · Cited by 41
Microsphere Absorption by the Nasal Mucosa of the Rat
Alpar, H. O., Almeida, A. J., & Brown, M. R. (1994) · Journal of drug targeting · doi:10.3109/10611869409015903 · Cited by 41
Self-citationComing of age of lipid-based drug delivery systems
Davis, S. S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.001 · Cited by 32
Poyner, E. A., Alpar, H. O., Almeida, A. J., Gamble, M. D., & Brown, M. R. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00017-3 · Cited by 32
Self-citationPreparation and characterization of a peptide containing w/o emulsion
Trenktrog, T. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00057-p · Cited by 20
Liposomes for Local Sustained Drug Release
Oussoren, C., Storm, G., Crommelin, D. J. A., & Senior, J. (2000) · CRC Press eBooks · doi:10.1201/b14421-8 · Cited by 7
Cited by
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Advanced materials and processing for drug delivery: The past and the future
Zhang, Y., Chan, H. F., & Leong, K. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.003 · Cited by 1,000
Mohammadi-Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 970
Targeting nanoparticles to cancer
Wang, M., & Thanou, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.005 · Cited by 931
Metadata
- Authors
- ALMEIDA, A., & SOUTO, E.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2007-07-10
- Volume
- 59
- Issue
- 6
- Pages
- 478-490
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2065254628
- Cited by
- 814
- References
- 94
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.